Please select the eligibility criteria that correspond to the clinical trial below.
Title: Acceptability of a Locally-Produced Multiple Micronutrient-Fortified Lipid-Based Nutrient Supplement (LNS) for Children Under Two Years in Cambodia
Brief Summary: The purpose of this trial is to evaluate the acceptability of the LNS to women and their children aged 12-17 months in comparison to Corn Soy Blend++, and Sprinkles added to borbor (white rice porridge, which is the traditional weaning food in Cambodia). Acceptability will be assessed through a sensory test for caregivers, and by measuring children's consumption.


Options:
A: Inclusion Criteria:

* Children aged 9-23 months and their caregivers
* Have been eating solids for at least three months
* Singletons
* Normally nourished or only moderately malnourished (MUAC \>115mm, WHZ score \>-3)
* Healthy (no ill-health in past three days)
* No known food intolerances
* Have not been using Sprinkles, CSB++ or similar supplementary foods or supplements
* Informed signed consent of mother
* Mothers are healthy

Exclusion Criteria:

* Children \<9 months or \>23mths
* Not yet eating solid food for at least three months
* Twins/multiples
* Severely malnourished (MUAC\< 115mm, WHZ score\<3, bipedal pitting oedema).
* Oedema and/or any medical complications at recruitment or illness requiring referral, or any ill health in past three days.
* Known intolerances
* Children enrolled in Sprinkles, CSB++ or similar program
* No informed signed consent of caregiver
* Medical complications or illness requiring referral at time of recruitment or previous two weeks
B: Inclusion Criteria:

* Confirmed maternal HIV-infection
* Age 5.5-6.5 months at intervention start
* Weight-for-length z-score \> -3 SD (WHO 2006 reference)

Exclusion Criteria:

* Confirmed or suspected allergy to peanuts
* Participation in a concurrent clinical trial at GHESKIO
C: Study participants will be women who are rural residents of Chirumanzu or Shurugwi districts in Zimbabwe and who become pregnant during the enrollment period of the trial and are identified and consent to participation during pregnancy, and their live born infants. A total of 5280 women will be enrolled.

Inclusion Criteria:

Pregnant women residing in the study districts, whose pregnancy is confirmed by a urine pregnancy test.

Exclusion Criteria:

* Women residing in the study districts who become pregnant during the enrollment period but do not consent to join the trial
* Women who reside in urban areas of these two districts
* Infants with major non-fatal abnormalities will not be excluded from study procedures, but will be excluded from the final analytic sample if the abnormality is likely to directly affect gut health/function or stature (e.g. neural tube defects, cerebral palsy, Down syndrome)
D: Cross-sectional study (baseline and endline)

Inclusion Criteria:

* At least one index child 6-23 months of age in the household
* Mother should be living in the study area since the index child's delivery
* Singleton infants

Exclusion Criteria:

* Index child should not present congenital deformations that hamper anthropometric measurements

Longitudinal study

Inclusion Criteria:

* Child 6-6.9 months of age;
* Child with WHZ\>-2 and MUAC\>125 mm and no bilateral pitting edema
* Mother should be living in the study area since the index child's delivery
* Singleton infants

Exclusion Criteria:

* Congenital malformations that make anthropometric measurements impossible
* Mother planning to leave the study are in the coming year

Answer: A